Expanding Access of HIV Prevention Injection to Include Adolescents: MU-JHU

Researchers from the collaborative effort between Mulago-based Makerere University and Johns Hopkins University (MU-JHU) have disclosed that the soon-to-be-approved long-acting Cabotegravir injection, designed to prevent HIV, is deemed safe for adolescents. The administration of this HIV-preventing drug involves initial injections four weeks apart, followed by subsequent injections every eight weeks. The drug is intended for…

Uganda: Poor Nutrition evades suppressing HIV for Children living with HIV

Experts are concerned that Uganda may not meet its commitment to defeating HIV as an epidemic by 2030, as children living with the virus struggle to stay on treatment.    Michael Byamukama, the Country Director of the Regional Psycho-social Support Initiative (REPSSI), reports that the biggest reason children abandon treatment is lack of food.  When…